Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

N.C. Tebutt; K. Wilson; V.J. Gebski; M.M. Cummins; D. Zannino; Guy Van Hazel; B. Robinson; A. Broad; V. Ganiu; S.P. Ackland; G. Forgeson; D. Cunningham; M.P. Saunders; M.R. Stockler; Y. Chua; J.R. Zalbcberg; R.J. Simes; T.J. Price

doi:10.1200/JCO.2009.27.7723

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

N.C. Tebutt, K. Wilson, V.J. Gebski, M.M. Cummins, D. Zannino, Guy Van Hazel, B. Robinson, A. Broad, V. Ganiu, S.P. Ackland, G. Forgeson, D. Cunningham, M.P. Saunders, M.R. Stockler, Y. Chua, J.R. Zalbcberg, R.J. Simes, T.J. Price

Research output: Contribution to journal › Article › peer-review

323 Citations (Scopus)

Original language	English
Pages (from-to)	3191-3198
Journal	Journal of Clinical Oncology
Volume	28
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2009.27.7723
Publication status	Published - 2010

Access to Document

10.1200/JCO.2009.27.7723

Cite this

Tebutt, N. C., Wilson, K., Gebski, V. J., Cummins, M. M., Zannino, D., Van Hazel, G., Robinson, B., Broad, A., Ganiu, V., Ackland, S. P., Forgeson, G., Cunningham, D., Saunders, M. P., Stockler, M. R., Chua, Y., Zalbcberg, J. R., Simes, R. J., & Price, T. J. (2010). Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. Journal of Clinical Oncology, 28(19), 3191-3198. https://doi.org/10.1200/JCO.2009.27.7723

Tebutt, N.C. ; Wilson, K. ; Gebski, V.J. ; Cummins, M.M. ; Zannino, D. ; Van Hazel, Guy ; Robinson, B. ; Broad, A. ; Ganiu, V. ; Ackland, S.P. ; Forgeson, G. ; Cunningham, D. ; Saunders, M.P. ; Stockler, M.R. ; Chua, Y. ; Zalbcberg, J.R. ; Simes, R.J. ; Price, T.J. / Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. In: Journal of Clinical Oncology. 2010 ; Vol. 28, No. 19. pp. 3191-3198.

@article{f29883de290a40af8976f0a6b664936b,

title = "Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study",

author = "N.C. Tebutt and K. Wilson and V.J. Gebski and M.M. Cummins and D. Zannino and {Van Hazel}, Guy and B. Robinson and A. Broad and V. Ganiu and S.P. Ackland and G. Forgeson and D. Cunningham and M.P. Saunders and M.R. Stockler and Y. Chua and J.R. Zalbcberg and R.J. Simes and T.J. Price",

year = "2010",

doi = "10.1200/JCO.2009.27.7723",

language = "English",

volume = "28",

pages = "3191--3198",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "19",

}

Tebutt, NC, Wilson, K, Gebski, VJ, Cummins, MM, Zannino, D, Van Hazel, G, Robinson, B, Broad, A, Ganiu, V, Ackland, SP, Forgeson, G, Cunningham, D, Saunders, MP, Stockler, MR, Chua, Y, Zalbcberg, JR, Simes, RJ & Price, TJ 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, no. 19, pp. 3191-3198. https://doi.org/10.1200/JCO.2009.27.7723

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. / Tebutt, N.C.; Wilson, K.; Gebski, V.J.; Cummins, M.M.; Zannino, D.; Van Hazel, Guy; Robinson, B.; Broad, A.; Ganiu, V.; Ackland, S.P.; Forgeson, G.; Cunningham, D.; Saunders, M.P.; Stockler, M.R.; Chua, Y.; Zalbcberg, J.R.; Simes, R.J.; Price, T.J.

In: Journal of Clinical Oncology, Vol. 28, No. 19, 2010, p. 3191-3198.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

AU - Tebutt, N.C.

AU - Wilson, K.

AU - Gebski, V.J.

AU - Cummins, M.M.

AU - Zannino, D.

AU - Van Hazel, Guy

AU - Robinson, B.

AU - Broad, A.

AU - Ganiu, V.

AU - Ackland, S.P.

AU - Forgeson, G.

AU - Cunningham, D.

AU - Saunders, M.P.

AU - Stockler, M.R.

AU - Chua, Y.

AU - Zalbcberg, J.R.

AU - Simes, R.J.

AU - Price, T.J.

PY - 2010

Y1 - 2010

U2 - 10.1200/JCO.2009.27.7723

DO - 10.1200/JCO.2009.27.7723

M3 - Article

VL - 28

SP - 3191

EP - 3198

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

SN - 0732-183X

IS - 19

ER -